Login / Signup

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.

Alessio CortelliniMaria G VitaleFederica De GalitiisFrancesca R Di PietroRossana BerardiMariangela TorniaiMichele De TursiAntonino GrassadoniaPietro Di MarinoDaniele SantiniTea ZeppolaCecilia AnesiAlain GelibterMario Alberto OcchipintiAndrea BotticelliPaolo MarchettiFrancesca RastelliFederica PergolesiMarianna TudiniRosa Rita SilvaDomenico MallardoVito VanellaCorrado FicorellaGiampiero PorzioPaolo A Ascierto
Published in: Journal of translational medicine (2019)
Early ir-fatigue seems to be negative prognostic parameter, but to proper weight its role we must to consider the predominant role of performance status, which was related to early ir-fatigue in the study population.
Keyphrases
  • clinical practice
  • sleep quality
  • dna damage
  • body mass index
  • squamous cell carcinoma
  • cell proliferation
  • depressive symptoms
  • squamous cell